“…Recent mouse studies using genetic techniques for cell-specific manipulation and cell lineage tracking have identified a population of intestinal stem cells called crypt base columnar cells (Barker et al, 2007) that can serve as the cell of origin of CRC (Barker et al, 2009). While intestinal stem cells are not the only cell capable of serving as the cell of origin (Visvader, 2011), they are by far the most efficient, requiring only a single activating mutation of the WNT/β-catenin pathway - a frequent event associated with the progression of the majority of CRCs, such as APC mutations in adenocarcinomas (Clevers and Nusse, 2012; Sekine et al, 2016). Paradoxically, despite a high prevalence among colorectal tumors, ectopic expression of an oncogenic BRAF mutant transgene promotes either senescence or differentiation of intestinal stem cells (Carragher et al, 2010; Riemer et al, 2015).…”